Oral methotrexate and vaginal misoprostol for early abortion

Contraception

Volumn 57, Issue 2, 1998, Pages 83-88

  Carbonell, J L L ^a   Varela, L ^b   Velazco, A ^b   Cabezas, E ^b   Fernandez C ^b   Sanchez C ^b  

^a Family Planning Center   (Spain)

^b Hosp Docente Gineco O   (Cuba)

Author keywords

Methotrexate; Misoprostol; Pregnancy termination

Indexed keywords

ANTIGESTAGEN; METHOTREXATE; MISOPROSTOL; PROSTAGLANDIN;

ABORTION; ADULT; ARTICLE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PAIN; STATISTICAL ANALYSIS; VAGINA BLEEDING;

ABORTIFACIENT AGENTS; ABORTION, DRUG INDUCED; ABORTION, INDUCED; AMERICAS; BIOLOGY; CARIBBEAN; CUBA; DEVELOPING COUNTRIES; ENDOCRINE SYSTEM; FAMILY PLANNING; FERTILITY CONTROL, POSTCONCEPTION; LATIN AMERICA; MISOPROSTOL; NORTH AMERICA; PHYSIOLOGY; PROSPECTIVE STUDIES; PROSTAGLANDINS; PROSTAGLANDINS, SYNTHETIC; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; FEMALE; GESTATIONAL AGE; HUMANS; METHOTREXATE; MISOPROSTOL; PREGNANCY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031978426     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00004-3     Document Type: Article

References (17)

1. Creinin MD, Darney PD. Methotrexate and misoprostol for early abortion. Contraception. 48:1993;339-348.
2. Creinin MD, Vittinghoff E. Methotrexate and misoprostol versus misoprostol alone for early abortion a randomized trial . JAMA. 272:1994;1190-1195.
3. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. A randomized trial comparing misoprostol 3 and 7 days following methotrexate for early abortion. Am J Obstet Gynecol. 173:1995;1578-1584.
4. Schaff E, Eisinger SH, Franks P, Kim SS. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med. 4:1995;774-779.
5. Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G. Methotrexate and misoprostol for early abortion a multicentre trial. I. Safety and efficacy . Contraception. 53:1996;321-327.
6. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med. 333:1995;537-540.
7. Creinin MD. Oral methotrexate and vaginal misoprostol for early abortion. Contraception. 54:1996;15-18.
8. Halprin KM, Fukui K, Ohkawara A. Blood levels of methotrexate and the treatment of psoriasis. Arch Drem. 103:1971;243-249.
9. Henderson ES, Adamson RH, Oliverio VT. The metabolic fate of titrated methotrexate. II. Absorption and excretion in man. Cancer Res. 25:1965;1018-1024.
10. Oguey D, Kölliker F, Gerber NJ, Reichen J. Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis. Arthrit Rheumat. 35:1992;611-614.
11. Shen DD, Azarnoff DL. Clinical pharmacokinetics of methotrexate. Clin Pharmacokinet. 3:1978;1-13.
12. Carbonell JLL, Varela L, Valazco A, Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception. 55:1997;165-168.
13. Koopersmith TB, Mishell DR Jr. The use of misoprostol for termination of early pregnancy. Contraception. 53:1996;237-242.
14. Bugalho A, Faúndes A, Jamisse L, Usfá M, Maria E, Bique C. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception. 53:1996;243-246.
15. Goldstein SR, Wolfson R. Endovaginal ultrasongraphic measurements of early embryonic size as a means of assessing gestational age. J Ultrasound Med. 13:1994;27-31.
16. Rochon R. The Application of the GSK method to the determination of minimum sample size. Biometrics. 45:1989;193-205.
17. Carbonell JLL, Varela L, Velazco A, Cabezas E, Fernández C, Sánchez C. Misoprostol 3, 4 or 5 days after methotrexate for early abortion. A randomized trial. Contraception. 56:1997;169-174.